<h1>CDPQ's Investment in API Holdings Approved: Boost for PharmEasy and Healthcare Services in India.</h1> The Competition Commission of India has approved the subscription of Compulsorily Convertible Preference Shares (CCPS B) in API Holdings Ltd. by CDPQ Private Equity Asia Pte Ltd. CDPQ Private Equity Asia, a subsidiary of Canadian institutional fund CDPQ, will invest in API Holdings, which operates healthcare services including the PharmEasy e-commerce platform, pharmaceutical wholesale, and diagnostic services. This investment will occur through a Rights Issue, with CDPQ as a pre-emption right holder and existing investor. The transaction involves a primary subscription and grants certain rights to the acquirer. A detailed CCI order will be issued subsequently.